• Info
  • Insider Ownership

Insider Trading & Ownership of Matthew W. Strobeck

Location
Cambridge, MA
Summary
The estimated net worth of Matthew W. Strobeck is at least $4,983,387 dollars as of 13 Feb 2026. Matthew W. Strobeck is the Director of QuidelOrtho Corp and owns shares of QuidelOrtho Corp (QDEL) stock worth about $2.49M. Matthew W. Strobeck is the Director of Accelerate Diagnostics, Inc and owns shares of Accelerate Diagnostics, Inc stock worth about $2.47M. Matthew W. Strobeck is the Director of BIODESIX INC and owns shares of BIODESIX INC (BDSX) stock worth about $22.6K.
Signature
/s/ Phillip S. Askim, attorney-in-fact for Matthew W. Strobeck
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Matthew W. Strobeck and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Matthew W. Strobeck has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $4,983,387.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: QuidelOrtho Corp ($2,493,291).
  • Past-year value change for that position: +$239,586.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Matthew W. Strobeck

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
QDEL QuidelOrtho Corp Director $2,493,291 +$239,586 +11% 13 Feb 2026
AXDX Accelerate Diagnostics, Inc Director $2,467,531 23 Jan 2024
BDSX BIODESIX INC Director $22,565 02 Jan 2026
QDEL QUIDEL CORP /DE/ Director 27 May 2022

Insider Transactions Reported by Matthew W. Strobeck:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.